deltatrials
Completed PHASE4 INTERVENTIONAL 1-arm NCT06588530

PFAS Exposure and Immune Response to Vaccination in Adults

Effects of Exposure to Per- and Polyfluoroalkyl Substances (PFAS) on Innate and Adaptive Immune Responses to Tetanus-diphtheria (Td) Vaccination Among Adults in a Community-based Panel Study

Sponsor: Rutgers, The State University of New Jersey

Conditions Adult Antibodies Diphtheria Environmental Exposure Immunity Innate Inflammatory Response Pollution; Exposure Tetanus Vaccination Vaccine
Interventions TENIVAC
Updated 3 times since 2024 Last updated: Dec 16, 2025 Started: Nov 4, 2024 Primary completion: Jan 8, 2025 Completion: Jan 8, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06588530, this PHASE4 trial focuses on Adult and Antibodies and remains completed. Sponsored by Rutgers, The State University of New Jersey, it has been updated 3 times since 2024, reflecting limited change activity. Mental health research at this phase helps define safety and dosing parameters for future study.

Status Flow

~Oct 2024 – ~Jun 2025 · 8 months · monthly snapshotNot Yet Recruiting~Jun 2025 – ~Jan 2026 · 7 months · monthly snapshotCompleted~Jan 2026 – present · 6 months · monthly snapshotCompleted

Change History

3 versions recorded

  1. Jan 2026 — Present [monthly]

    Completed PHASE4

  2. Jun 2025 — Jan 2026 [monthly]

    Completed PHASE4

    Status: Not Yet Recruiting → Completed

  3. Oct 2024 — Jun 2025 [monthly]

    Not Yet Recruiting PHASE4

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Rutgers, The State University of New Jersey
Data source: Rutgers, The State University of New Jersey

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations